Compass Therapeutics CMPX
NASDAQ CMPX
$0.83 -0.01 (-0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Compass Therapeutics (CMPX) Price to Sales (2024 - 2025)

Updated

Compass Therapeutics' Price to Sales was 422.98 in Q2 2025, up 161.3% from 161.87 a year earlier.

Analysis

Compass Therapeutics (CMPX) Price to Sales (2024 - 2025) Analysis & Trends

For FY2024, Price to Sales at Compass Therapeutics came in at 235.10.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Compass Therapeutics 151.27 Mn -597.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 422.98
Dec 31, 2024 235.10
Sep 30, 2024 297.84
Jun 30, 2024 161.87
API Access

Compass Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CMPX&period=max&api_key=YOUR_API_KEY